329 related articles for article (PubMed ID: 25845230)
1. [G-quadruplex ligands: mechanisms of anticancer action and target binding].
Il'inskiĭ NS; Varizhuk AM; Beniaminov AD; Puzanov MA; Shchelkina AK; Kaliuzhnyĭ DN
Mol Biol (Mosk); 2014; 48(6):891-907. PubMed ID: 25845230
[TBL] [Abstract][Full Text] [Related]
2. Energetics of ligand binding to G-quadruplexes.
Giancola C; Pagano B
Top Curr Chem; 2013; 330():211-42. PubMed ID: 22851158
[TBL] [Abstract][Full Text] [Related]
3. Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands.
Kaulage MH; Maji B; Pasadi S; Ali A; Bhattacharya S; Muniyappa K
Eur J Med Chem; 2018 Mar; 148():178-194. PubMed ID: 29459277
[TBL] [Abstract][Full Text] [Related]
4. Quadruplex Nucleic Acids as Novel Therapeutic Targets.
Neidle S
J Med Chem; 2016 Jul; 59(13):5987-6011. PubMed ID: 26840940
[TBL] [Abstract][Full Text] [Related]
5. A Personal History of Quadruplex-Small Molecule Targeting.
Neidle S
Chem Rec; 2015 Aug; 15(4):691-710. PubMed ID: 26096791
[TBL] [Abstract][Full Text] [Related]
6. Reduced or diminished stabilization of the telomere G-quadruplex and inhibition of telomerase by small chemical ligands under molecular crowding condition.
Chen Z; Zheng KW; Hao YH; Tan Z
J Am Chem Soc; 2009 Aug; 131(30):10430-8. PubMed ID: 19588966
[TBL] [Abstract][Full Text] [Related]
7. Platinum squares with high selectivity and affinity for human telomeric G-quadruplexes.
Zheng XH; Chen HY; Tong ML; Ji LN; Mao ZW
Chem Commun (Camb); 2012 Aug; 48(61):7607-9. PubMed ID: 22728887
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex structures and their interaction diversity with ligands.
Zhang S; Wu Y; Zhang W
ChemMedChem; 2014 May; 9(5):899-911. PubMed ID: 24729465
[TBL] [Abstract][Full Text] [Related]
9. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
11. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
12. Dimeric 1,3-phenylene-bis(piperazinyl benzimidazole)s: synthesis and structure-activity investigations on their binding with human telomeric G-quadruplex DNA and telomerase inhibition properties.
Jain AK; Paul A; Maji B; Muniyappa K; Bhattacharya S
J Med Chem; 2012 Apr; 55(7):2981-93. PubMed ID: 22452380
[TBL] [Abstract][Full Text] [Related]
13. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies.
Islam MK; Jackson PJ; Rahman KM; Thurston DE
Future Med Chem; 2016 Jul; 8(11):1259-90. PubMed ID: 27442231
[TBL] [Abstract][Full Text] [Related]
15. Contribution of telomere G-quadruplex stabilization to the inhibition of telomerase-mediated telomere extension by chemical ligands.
Chen CY; Wang Q; Liu JQ; Hao YH; Tan Z
J Am Chem Soc; 2011 Sep; 133(38):15036-44. PubMed ID: 21846102
[TBL] [Abstract][Full Text] [Related]
16. Discovery of selective ligands for telomeric RNA G-quadruplexes (TERRA) through 19F-NMR based fragment screening.
Garavís M; López-Méndez B; Somoza A; Oyarzabal J; Dalvit C; Villasante A; Campos-Olivas R; González C
ACS Chem Biol; 2014 Jul; 9(7):1559-66. PubMed ID: 24837572
[TBL] [Abstract][Full Text] [Related]
17. G-quadruplexes: targets and tools in anticancer drug design.
Düchler M
J Drug Target; 2012 Jun; 20(5):389-400. PubMed ID: 22424091
[TBL] [Abstract][Full Text] [Related]
18. Function and targeting of G-quadruplexes.
Wong HM; Payet L; Huppert JL
Curr Opin Mol Ther; 2009 Apr; 11(2):146-55. PubMed ID: 19330720
[TBL] [Abstract][Full Text] [Related]
19. Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity.
Castillo-González D; Pérez-Machado G; Pallardó F; Garrigues-Pelufo TM; Cabrera-Pérez MA
Curr Top Med Chem; 2012; 12(24):2843-56. PubMed ID: 23368106
[TBL] [Abstract][Full Text] [Related]
20. [G-quadruplex DNA: myth or reality?].
Riou JF; Gomez D; Lemarteleur T; Trentesaux C
Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
